Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (295)
- Advertising (25)
- Safety monitoring and information (23)
- Manufacturing (11)
- Scheduling (national classification system) (10)
- COVID-19 (7)
- Clinical trials (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
567 result(s) found, displaying 451 to 475
-
Corporate reportsInfographic - Half Yearly Performance Snapshot - 1 July to 31 December 2015
-
Corporate reportsOTC application placement question and answer tool
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 308 statement, 5 February 2016
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 307 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 306 statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the sixth time on 17 February 2015
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the seventh time on 4 August 2015
-
Meeting statementsThe meeting statement for the Therapeutic Goods Committee is now available
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 305 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 22 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 21 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 304 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 6 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 20 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 302 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 303 statement
-
Corporate reportsReporting medical device adverse incidents
-
Corporate reportsEach year, approximately 40 new prescription medicines containing new active substances are registered.
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 19 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 18 meeting statement
-
Corporate reportsThe Scheduling Policy Framework (SPF) is a key feature of the revised arrangements for scheduling of medicines and chemicals
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 301 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 16 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 17 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement